Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/22/2001WO2001088140A1 Polypeptide involved in cell adhesion and phagocytosis and its use in treatment
11/22/2001WO2001088139A2 Proteins interacting with a sucrose transporter
11/22/2001WO2001088137A2 Human myd88 adapter-like protein and functional fragments thereof
11/22/2001WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001WO2001088135A2 G-protein coupled receptor proteins and nucleic acids encoding same
11/22/2001WO2001088134A2 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001WO2001088133A2 Human semaphorin homologs and polynucleotides encoding the same
11/22/2001WO2001088130A1 Molecular cloning and identification of a human leukotriene-like receptor ltxr
11/22/2001WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001WO2001088127A2 Regulation of human follicle stimulating hormone-like g protein-coupled receptor
11/22/2001WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001WO2001088122A2 Erg modulators
11/22/2001WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001WO2001088118A1 Novel motor proteins and methods for their use
11/22/2001WO2001088117A2 In vitro fucosylation recombinant glycopeptides
11/22/2001WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001WO2001088115A1 Transgenic caenorhabditis elegans model exhibiting a neuronal dysfunction
11/22/2001WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001WO2001088101A2 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
11/22/2001WO2001088092A2 Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides
11/22/2001WO2001088091A2 Novel bone marrow nucleic acids and polypeptides
11/22/2001WO2001088090A2 Cng3b: a novel cyclic nucleotide-gated cation channel
11/22/2001WO2001088088A2 Novel nucleic acids and polypeptides
11/22/2001WO2001088085A2 Novel bee venom polypeptides and methods of use thereof
11/22/2001WO2001088059A1 Drilling fluids and method of drilling
11/22/2001WO2001088017A1 Polypeptide derivatives and nucleic acid carriers containing the same
11/22/2001WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001WO2001087978A2 Human abc transporter and its use
11/22/2001WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001WO2001087972A1 A novel polypeptide-human tumor-inhibiting factor dpc4 protein 9 and a polynucleotide encoding the same
11/22/2001WO2001087971A1 A novel polypeptide, human ribosomal protein s18-14 and the polynucleotide encoding thereof
11/22/2001WO2001087969A1 A novel polypeptide, human sox9 protein 13 and the polynucleotide encoding thereof
11/22/2001WO2001087968A1 A novel polypeptide -human ribosomal protein s4-36 and a polynucleotide encoding the same
11/22/2001WO2001087967A1 A novel polypeptide -human ribosomal protein s18-26 and a polynucleotide encoding the same
11/22/2001WO2001087966A1 A new polypeptide-human pax protein 22 and the polynucleotide encoding it
11/22/2001WO2001087965A1 A novel polypeptide -human synapse channel-assocaited protein 15 and a polynucleotide encoding the same
11/22/2001WO2001087964A1 A new polypeptide- human gap connexin 15 and the polynucleotide encoding it
11/22/2001WO2001087963A1 A new polypeptide- human ribosomal protein s18-12 and the polynucleotide encoding it
11/22/2001WO2001087962A1 A new polypeptide-human pax protein 11 and the polynucleotide encoding it
11/22/2001WO2001087961A1 A new polypeptide-human pax protein 11.4 and the polynucleotide encoding it
11/22/2001WO2001087960A1 A new polypeptide-human kruppel-related dna-binding protein 10 and the polynucleotide encoding it
11/22/2001WO2001087959A1 A new polypeptide-human pax protein 11.9 and the polynucleotide encoding it
11/22/2001WO2001087958A2 CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
11/22/2001WO2001087954A1 A novel polypeptide, a human clathrin light chain 9 and the polynucleotide encoding the polypeptide
11/22/2001WO2001087952A1 A novel polypeptide-homo ribosomal protein 13 and polynucleotide encoding said polypeptide
11/22/2001WO2001087950A1 A novel polypeptide -human cannabinoid receptor 11 and the polynucleotide encoding said polypeptide
11/22/2001WO2001087949A1 A novel polypeptide- human pax protein 9 and the polynucleotide encoding said polypeptide
11/22/2001WO2001087947A1 A novel polypeptide-human ccr4 protein 10 and the polynucleotide encoding said polypeptide
11/22/2001WO2001087945A1 The novel polypeptide-human laminin b2 chain 12 and the polynucliotide encoding said polypeptide
11/22/2001WO2001087941A1 A novel polypeptide-human kringle protein 14 and the polynucleotide encoding said polypeptide
11/22/2001WO2001087940A2 Polypeptide composionns toxic to anthonomus insects, and use thereof
11/22/2001WO2001087939A2 Genes required for natural competence, proteins, and their use
11/22/2001WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001WO2001087937A2 G-protein coupled receptors
11/22/2001WO2001087936A2 Isolation of micromonospora carbonacea var africana pmlp1 integrase and use of integrating function for site-specific integration into micromonospora halophitica and micromonospora carbonacea chromosome
11/22/2001WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001WO2001087933A2 Zsig33-like peptides
11/22/2001WO2001087932A2 Seven transmembrane proteins and polynucleotides encoding the same
11/22/2001WO2001087931A2 Bacterial insecticidal proteins
11/22/2001WO2001087930A2 Human galanin receptor-like g protein coupled receptor
11/22/2001WO2001087929A2 Regulation of human dopamine-like g protein-coupled receptor
11/22/2001WO2001087928A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
11/22/2001WO2001087925A2 Methods for refolding proteins containing free cysteine residues
11/22/2001WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001WO2001087922A2 Derivatisation of proteins in aqueous solution
11/22/2001WO2001087921A2 Gene responsible for stargardt-like dominant macular dystrophy
11/22/2001WO2001087919A2 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
11/22/2001WO2001087918A1 Methods for identifying novel therapeutics and diagnostics in the p53 pathway
11/22/2001WO2001087917A1 Novel nucleic acids and polypeptides
11/22/2001WO2001087916A1 A novel peptide---human ribosomal protein s5-13 and the polynucleotide coding this novel peptide
11/22/2001WO2001087915A1 A novel peptide---human gm2 activiation protein 14 and the polynucleotide coding this novel peptide
11/22/2001WO2001087911A1 Method of identifying critical points within protein-protein interactions
11/22/2001WO2001087910A2 Haplotypes of the gnrh2 gene
11/22/2001WO2001087903A2 Haplotypes of the acaa1 gene
11/22/2001WO2001087349A1 Carcinostatic agents or antiviral agents containing irg27 protein or gene
11/22/2001WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001WO2001087329A1 Liquid pharmaceutical composition containing an erythropoietin derivate
11/22/2001WO2001087327A1 Method for cell adhesion and wound healing
11/22/2001WO2001087323A2 Method for treating cartilage disorders
11/22/2001WO2001087285A2 Inhibition of the interaction of psd93 and psd95 with the nnos and nmda receptors
11/22/2001WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001WO2001087239A2 Methods of affecting laminin 5 processing
11/22/2001WO2001087238A2 Induction of apoptosis and cell growth inhibition by protein 4.33
11/22/2001WO2001087233A2 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof
11/22/2001WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001WO2001049714A3 Nope polypeptides, encoding nucleic acids and methods of use
11/22/2001WO2001042442A3 Activation of endogenous genes by genomic introduction of a replicon
11/22/2001WO2001038355A3 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
11/22/2001WO2001036977A3 Identification of disease markers involving mass-based-separation
11/22/2001WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001WO2001036588A3 Fusion proteins that specifically inhibit protein synthesis in neuronal cells
11/22/2001WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001WO2001036465A3 Human zven proteins
11/22/2001WO2001036463A3 Genes specifically expressed in human dendritic cells